Monoglycosylated SARS-CoV-2 receptor binding domain fused with HAstem-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza viruses
- Resource Type
- Article
- Source
- In
Antiviral Research December 2023 220 - Subject
- Language
- ISSN
- 0166-3542